Literature DB >> 23904697

Role of 17 α Hydroxy Progesterone Caproate (17OHPC) in the Prevention of Preterm Labor.

Asma Nigar1, S Hakim, Zehra Mohsin.   

Abstract

OBJECTIVE: To evaluate the role of 17 α hydroxyprogesterone caproate (17OHPC) in the prevention of preterm labor in high risk asymptomatic patients with a history of preterm delivery.
METHODS: The study included 96 patients with a singleton pregnancy and having a prior preterm birth. They were divided in 2 groups, group I (treatment group) included 46 asymptomatic patients who were given 17OHPC injections starting from 16-20 weeks till 36 weeks and group II (control group) included 50 patients who did not receive any treatment.
RESULTS: The incidence of preterm delivery was found to be 6.9 %. The median gestational age at delivery was 36 weeks in group I and 33 W5D in controls. 50 % cases in group I and 80 % of controls delivered prematurely in the group with a prior preterm birth between 20-28 weeks.
CONCLUSION: In patients who had a prior history of a preterm delivery the recurrence of a preterm birth was less in the treated group as compared to controls. The median gestational age at delivery was significantly higher in 17OHPC treated patients with history of earliest prior preterm delivery at 20-28 weeks.

Entities:  

Year:  2012        PMID: 23904697      PMCID: PMC3500942          DOI: 10.1007/s13224-012-0290-1

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  7 in total

1.  Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery.

Authors:  Catherine Y Spong; Paul J Meis; Elizabeth A Thom; Baha Sibai; Mitchell P Dombrowski; Atef H Moawad; John C Hauth; Jay D Iams; Michael W Varner; Steve N Caritis; Mary J O'Sullivan; Menachem Miodovnik; Kenneth J Leveno; Deborah Conway; Ronald J Wapner; Marshall Carpenter; Brian Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman; Steven Gabbe
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

Review 2.  17 hydroxyprogesterone for the prevention of preterm delivery.

Authors:  Paul J Meis
Journal:  Obstet Gynecol       Date:  2005-05       Impact factor: 7.661

3.  Recurrence of preterm birth in singleton and twin pregnancies.

Authors:  S L Bloom; N P Yost; D D McIntire; K J Leveno
Journal:  Obstet Gynecol       Date:  2001-09       Impact factor: 7.661

4.  ACOG Committee Opinion. Use of progesterone to reduce preterm birth.

Authors: 
Journal:  Obstet Gynecol       Date:  2003-11       Impact factor: 7.661

5.  Serum progesterone and estradiol-17beta levels in premature and term labor.

Authors:  L M Cousins; C J Hobel; R J Chang; D M Okada; J R Marshall
Journal:  Am J Obstet Gynecol       Date:  1977-03-15       Impact factor: 8.661

6.  Implications of idiopathic preterm delivery for previous and subsequent pregnancies.

Authors:  J Kristensen; J Langhoff-Roos; F B Kristensen
Journal:  Obstet Gynecol       Date:  1995-11       Impact factor: 7.661

7.  Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.

Authors:  Paul J Meis; Mark Klebanoff; Elizabeth Thom; Mitchell P Dombrowski; Baha Sibai; Atef H Moawad; Catherine Y Spong; John C Hauth; Menachem Miodovnik; Michael W Varner; Kenneth J Leveno; Steve N Caritis; Jay D Iams; Ronald J Wapner; Deborah Conway; Mary J O'Sullivan; Marshall Carpenter; Brian Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman; Steven Gabbe
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.